These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 15802193

  • 1. Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys.
    Chen L, Togasaki DM, Langston JW, Di Monte DA, Quik M.
    Neuroscience; 2005; 132(2):409-20. PubMed ID: 15802193
    [Abstract] [Full Text] [Related]

  • 2. Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
    Tamim MK, Samadi P, Morissette M, Grégoire L, Ouattara B, Lévesque D, Rouillard C, Di Paolo T.
    Neuropharmacology; 2010 Jan; 58(1):286-96. PubMed ID: 19576910
    [Abstract] [Full Text] [Related]

  • 3. Naltrexone in the short-term decreases antiparkinsonian response to l-Dopa and in the long-term increases dyskinesias in drug-naïve parkinsonian monkeys.
    Samadi P, Grégoire L, Hadj Tahar A, Di Paolo T, Rouillard C, Bédard PJ.
    Neuropharmacology; 2005 Aug; 49(2):165-73. PubMed ID: 15996565
    [Abstract] [Full Text] [Related]

  • 4. Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys.
    Morissette M, Samadi P, Hadj Tahar A, Bélanger N, Di Paolo T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):446-54. PubMed ID: 20026151
    [Abstract] [Full Text] [Related]

  • 5. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1999 Feb 16; 155(2):204-20. PubMed ID: 10072296
    [Abstract] [Full Text] [Related]

  • 6. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L, Frohna PA, Joyce JN, Schneider JS.
    Mov Disord; 1997 Mar 16; 12(2):148-58. PubMed ID: 9087972
    [Abstract] [Full Text] [Related]

  • 7. Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys.
    Hsu A, Togasaki DM, Bezard E, Sokoloff P, Langston JW, Di Monte DA, Quik M.
    J Pharmacol Exp Ther; 2004 Nov 16; 311(2):770-7. PubMed ID: 15226382
    [Abstract] [Full Text] [Related]

  • 8. Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G Proteins in the amygdala of fawn-hooded rats.
    Chen F, Lawrence AJ.
    J Pharmacol Exp Ther; 2004 Sep 16; 310(3):1020-6. PubMed ID: 15121763
    [Abstract] [Full Text] [Related]

  • 9. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
    Johansson PA, Andersson M, Andersson KE, Cenci MA.
    Neurobiol Dis; 2001 Apr 16; 8(2):220-39. PubMed ID: 11300719
    [Abstract] [Full Text] [Related]

  • 10. Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias.
    Riahi G, Morissette M, Parent M, Di Paolo T.
    Eur J Neurosci; 2011 May 16; 33(10):1823-31. PubMed ID: 21501255
    [Abstract] [Full Text] [Related]

  • 11. Effect of chronic ethanol and withdrawal on the mu-opioid receptor- and 5-Hydroxytryptamine(1A) receptor-stimulated binding of [(35)S]Guanosine-5'-O-(3-thio)triphosphate in the fawn-hooded rat brain: A quantitative autoradiography study.
    Chen F, Lawrence AJ.
    J Pharmacol Exp Ther; 2000 Apr 16; 293(1):159-65. PubMed ID: 10734165
    [Abstract] [Full Text] [Related]

  • 12. Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of L-Dopa in parkinsonian monkeys.
    Grégoire L, Samadi P, Graham J, Bédard PJ, Bartoszyk GD, Di Paolo T.
    Parkinsonism Relat Disord; 2009 Jul 16; 15(6):445-52. PubMed ID: 19196540
    [Abstract] [Full Text] [Related]

  • 13. Increases in striatal preproenkephalin gene expression are associated with nigrostriatal damage but not L-DOPA-induced dyskinesias in the squirrel monkey.
    Quik M, Police S, Langston JW, Di Monte DA.
    Neuroscience; 2002 Jul 16; 113(1):213-20. PubMed ID: 12123699
    [Abstract] [Full Text] [Related]

  • 14. Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias.
    Samadi P, Grégoire L, Morissette M, Calon F, Hadj Tahar A, Bélanger N, Dridi M, Bédard PJ, Di Paolo T.
    Neuropharmacology; 2008 Feb 16; 54(2):258-68. PubMed ID: 18001807
    [Abstract] [Full Text] [Related]

  • 15. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
    Morin N, Jourdain VA, Morissette M, Grégoire L, Di Paolo T.
    Neuropharmacology; 2014 Apr 16; 79():688-706. PubMed ID: 24456747
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
    Alt A, McFadyen IJ, Fan CD, Woods JH, Traynor JR.
    J Pharmacol Exp Ther; 2001 Jul 16; 298(1):116-21. PubMed ID: 11408532
    [Abstract] [Full Text] [Related]

  • 17. The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease.
    Koprich JB, Fox SH, Johnston TH, Goodman A, Le Bourdonnec B, Dolle RE, DeHaven RN, DeHaven-Hudkins DL, Little PJ, Brotchie JM.
    Mov Disord; 2011 Jun 16; 26(7):1225-33. PubMed ID: 21465551
    [Abstract] [Full Text] [Related]

  • 18. ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.
    Pavón N, Martín AB, Mendialdua A, Moratalla R.
    Biol Psychiatry; 2006 Jan 01; 59(1):64-74. PubMed ID: 16139809
    [Abstract] [Full Text] [Related]

  • 19. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.
    Guigoni C, Doudnikoff E, Li Q, Bloch B, Bezard E.
    Neurobiol Dis; 2007 May 01; 26(2):452-63. PubMed ID: 17350277
    [Abstract] [Full Text] [Related]

  • 20. Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain.
    Saland LC, Abeyta A, Frausto S, Raymond-Stintz M, Hastings CM, Carta M, Valenzuela CF, Savage DD.
    Alcohol Clin Exp Res; 2004 Jan 01; 28(1):98-104. PubMed ID: 14745307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.